BCAX
Bicara Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$19.19
-0.02 ▼ -0.10%
🌙 3월 13일 4:04 PM ET (한국 3/14 05:04)
$19.19
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -2.23 | Insider Own | 42% | Shs Outstand | 0.05B | Perf Week | 3.9% |
| Market Cap | 1.22B | Forward P/E | - | EPS next Y | -20.49% | Insider Trans | -0.4% | Shs Float | 0.03B | Perf Month | 29.66% |
| Enterprise Value | 0.93B | PEG | - | EPS next Q | -0.67 | Inst Own | 76.91% | Short Float | 29.17% | Perf Quarter | 0.42% |
| Income | -0.12B | P/S | - | EPS this Y | 37.91% | Inst Trans | 15.71% | Short Ratio | 17.28 | Perf Half Y | 60.18% |
| Sales | 0.00B | P/B | 2.6 | EPS next 5Y | 8.12% | ROA | -25.61% | Short Interest | 9.27M | Perf YTD | 14.02% |
| Book/sh | 7.38 | P/C | 4.19 | EPS past 3/5Y | -34% - | ROE | -26.64% | 52W High | -5.23% ($20.25) | Perf Year | 43.75% |
| Cash/sh | 4.58 | P/FCF | - | Sales past 3/5Y | - | ROIC | -30.1% | 52W Low | 146.03% ($7.80) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -103.95% | Gross Margin | - | Volatility(W/M) | 6.3% 6.94% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.15 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.14 | EPS Q/Q | -107.22% | Profit Margin | - | RSI (14) | 63.87 | Recom | 1.46 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.14 | Sales Q/Q | - | SMA20 | 10.77% ($17.32) | Beta | -1.06 | Target Price | $29.27 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 14.09% ($16.82) | Rel Volume | 0.65 | Prev Close | $19.21 |
| Employees | 55 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -23.82% - | SMA200 | 33.84% ($14.34) | Avg Volume(3M) | 0.54M | Price | $19.19 |
| IPO | 2024/9/13 | Option/Short | Yes/Yes | Trades | 6143 | Volume | 348,327 | Change | -0.1% |
뉴스 로딩 중...